Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) EBIT Margin (2016 - 2025)

Avanos Medical (AVNS) has disclosed EBIT Margin for 13 consecutive years, with 1.38% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 23440.0% to 1.38% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8.78% through Dec 2025, up 4882.0% year-over-year, with the annual reading at 8.78% for FY2025, 4882.0% up from the prior year.
  • EBIT Margin hit 1.38% in Q4 2025 for Avanos Medical, up from 0.06% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 9.14% in Q4 2022 to a low of 233.02% in Q4 2024.
  • Historically, EBIT Margin has averaged 14.87% across 5 years, with a median of 1.61% in 2021.
  • Biggest five-year swings in EBIT Margin: crashed -23948bps in 2024 and later soared 23440bps in 2025.
  • Year by year, EBIT Margin stood at 62.57% in 2021, then surged by 115bps to 9.14% in 2022, then fell by -29bps to 6.46% in 2023, then tumbled by -3706bps to 233.02% in 2024, then surged by 101bps to 1.38% in 2025.
  • Business Quant data shows EBIT Margin for AVNS at 1.38% in Q4 2025, 0.06% in Q3 2025, and 42.57% in Q2 2025.